Free Trial
NYSE:HQL

Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis

Abrdn Life Sciences Investors logo
$13.78 -0.04 (-0.29%)
(As of 11/22/2024 ET)

About Abrdn Life Sciences Investors Stock (NYSE:HQL)

Key Stats

Today's Range
$13.72
$13.90
50-Day Range
$13.72
$15.57
52-Week Range
$11.62
$15.90
Volume
116,392 shs
Average Volume
92,910 shs
Market Capitalization
$377.03 million
P/E Ratio
N/A
Dividend Yield
12.04%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
See More Headlines

HQL Stock Analysis - Frequently Asked Questions

Abrdn Life Sciences Investors' stock was trading at $13.46 at the start of the year. Since then, HQL stock has increased by 2.4% and is now trading at $13.7850.
View the best growth stocks for 2024 here
.

Top institutional investors of Abrdn Life Sciences Investors include Penserra Capital Management LLC (2.84%), Needham Investment Management LLC (1.29%), Allspring Global Investments Holdings LLC (1.02%) and Quarry LP (0.68%). Insiders that own company stock include Saba Capital Management, LP, Daniel R Omstead, Kathleen Goetz, Todd Reit and Rose Dimartino.
View institutional ownership trends
.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Ex-Dividend for 9/30 Dividend
8/23/2024
Dividend Payable
9/30/2024
Ex-Dividend for 1/10 Dividend
11/21/2024
Today
11/23/2024
Dividend Payable
1/10/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Finance
Industry
Investment offices, not elsewhere classified
Sub-Industry
Financial Services
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$39.95 million

Miscellaneous

Free Float
24,599,000
Market Cap
$377.03 million
Optionable
Not Optionable
Beta
0.73
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:HQL) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners